Sadatomo Tasaka

9PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical bacteriologyInnate immunityAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Nov 10, 2025
Reversible ST-T Segment Changes Induced by Anamorelin: A Case Report.

Hayato Akaishi, Tomonori Makiguchi, Yuji Ishida

|Oct 11, 2024
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi, Makoto Nishio, Hiroaki Akamatsu

|Jul 26, 2022
Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia.

Chiori Tabe, Masaki Dobashi, Yoshiko Ishioka

|Jan 16, 2021
Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung.

Masamichi Itoga, Hisashi Tanaka, Kageaki Taima

|May 14, 2020
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.

Kageaki Taima, Hisashi Tanaka, Masamichi Itoga

Pageof 2

Frequent Collaborators

1 joint publications

Hidetoshi Hayashi

1 joint publications

Makoto Nishio

1 joint publications

Hiroaki Akamatsu

1 joint publications

Yasushi Goto